• Trinity Pharma Solutions Announces the Next Generation of its Enterprise Cloud Data and Analytics Platform for Life Sciences

    Jun 2, 2015, 00:00 AM by Michael Croft
    WALTHAM, MA - Jun 2, 2015 - Trinity Pharma Solutions, a leader in cloud-based data and guided analytics solutions for the global life sciences industry, today announced the next generation of its cloud-enabled and mobile-ready data analytics platform
    Full story
  • Invitae Launches Direct-to-Consumer Pricing

    Jun 1, 2015, 14:00 PM by Michael Croft
    Bio-IT World | Invitae Corporation today announced a patient pay price for its full menu of genetic tests. For $475 per indication, patients can pay for their own genetic tests if insurance coverage is not available. The price covers all of Invitae’s offerings in cancer, cardiology, neurology, pediatric genetics, hematology and other rare conditions
    Full story
  • May News and Product Briefs

    Jun 1, 2015, 12:25 PM by Michael Croft
    Bio-IT World | News and product briefs from around the industry, including a suite of new proteomics and lipidomics solutions from SCIEX, and new efforts at the Broad Institute to understand the mechanisms of cancer drug resistance.
    Full story
  • Google cloud strategy focuses on analyzing big data

    Jun 1, 2015, 00:00 AM by Michael Croft
    Computerworld | Google may not have caught up to Amazon in the cloud market, but that's OK, according to a Google executive. The company is heading in a slightly different direction with cloud computing that involves helping customers analyze their data.
    Full story
  • Definiens Launches Biomarker Datafication Services

    May 29, 2015, 15:00 PM by Michael Croft
    Bio-IT World News Brief | Definiens today launched a new suite of Biomarker Datafication Services for oncology clinical development programs. The package provides image analysis screening of tissue samples for exploratory screening, pharmacokinetics/pharmacodynamics, and companion diagnostic development.
    Full story
  • PacBio Aims for Haplotyped Whole Genome Assemblies in Partnership with RainDance

    May 29, 2015, 11:50 AM by Michael Croft
    Bio-IT World | Months after 10X Genomics came to market with a platform for reassembling 100-kilobase DNA fragments with an Illumina sequencer, Pacific Biosciences and RainDance Technologies have teamed up on their own barcoded long read solution that they say could outperform 10X on virtually every count.
    Full story
  • Cenduit Reaches New Milestone of More Than 400 Employees

    May 29, 2015, 00:00 AM by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - May 29, 2015 - Cenduit, a joint venture between Quintiles and Thermo Fisher Scientific, today announced it has achieved a new milestone of more than 400 employees
    Full story
  • Strand LS Expands Cancer Profiling Service

    May 28, 2015, 10:00 AM by Michael Croft
    Bio-IT World News Brief | Strand Life Sciences announced an expanded StrandAdvantage pan-cancer genomic profiling service. The new version of StrandAdvantage will include a panel that examines 152 genes and pathways known to be impacted by existing targeted solid tumor therapies plus additional chemotherapeutic toxicity and resistance data.
    Full story
  • Rho Named a Best CRO with Life Sciences Award from the Triangle Business Journal

    May 28, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - May 28, 2015 - Rho Named a Best CRO with Life Sciences Award
    from the Triangle Business Journal
     Chapel Hill, NC  ̶  May 27, 2015  ̶  Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, recently announced that the company was recognized as one of the Best CROs by the Triangle Business Journal, a multimedia source for local business news, research and events in the Raleigh, Durham, Chapel Hill region of North Carolina, where Rho is headquartered
    Full story
  • Juno Therapeutics Partners with Editas Medicine on CRISPR-Engineered Cancer Immunotherapies

    May 27, 2015, 12:10 PM by Michael Croft
    Bio-IT World | Biotech funding must be hot indeed when an 18-month-old immunotherapy company can pledge hundreds of millions to an 18-month-old genome editing company, but there's plenty of promise combining CAR T therapy with CRISPR technology — as rivals Novartis and Intellia Therapeutics made clear when they forged their own partnership this January.
    Full story
  • QIAGEN Launches NGS Clinical Insights Platform

    May 27, 2015, 09:00 AM by Michael Croft
    Bio-IT World News Brief | Yesterday afternoon QIAGEN announced the commercial launch of QIAGEN Clinical Insight (QCI), a bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS). The first two supported applications for the bioinformatics platform are in oncology, for somatic and hereditary cancer testing. 
    Full story
  • New CLARITY Challenge Open to Entries, to Tackle Undiagnosed Diseases

    May 21, 2015, 10:00 AM by Michael Croft
    Clinical Informatics News | Boston Children’s Hospital is launching CLARITY Undiagnosed, a $25,000 competition to identify molecular diagnoses for five families with as-yet undiagnosed conditions. The Challenge kicks off in conjunction with a documentary film tracing the journeys of the patients and—possibly—the teams. Teams have until June 11 to register
    Full story
  • Genome in a Bottle Uncapped

    May 21, 2015, 09:40 AM by Michael Croft
    Bio-IT World | As the Genome in a Bottle Consortium and the National Institute of Standards and Technology announce the first reference DNA samples as trusted standards for genomic sequencing, the FDA weighs a regulatory role for the new reference material.
    Full story
  • Rho Showcases Clinical Services Expertise at OCT East Coast

    May 21, 2015, 00:00 AM by Michael Croft
    CHAPEL HILL, NC - May 21, 2015 -   Rho Showcases Clinical Services Expertise at OCT East Coast WHAT:           Rho, a full-service contract research organization (CRO), will highlight its continued success in drug development strategies and services during the 6th annual Outsourcing in Clinical Trials (OCT) East Coast conference, being held May 27-28 in King of Prussia, Pennsylvania
    Full story
  • KCR Accomplishes ISO 9001:2008 Certification for All Company Services

    May 21, 2015, 00:00 AM by Michael Croft
    BERLIN, GERMANY - May 21, 2015 - KCR, a Contract Research Organization (CRO), operating in 19 countries in Europe as well as the U.S., has recently validated the quality and accuracy of its operations receiving ISO 9001:2008 Certification for all its services
    Full story
  • Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With Advanced Lung Cancer

    May 21, 2015, 00:00 AM by Michael Croft
    BOULDER, CO, UNITED STATES - May 21, 2015 - BOULDER, Colo.—May 21, 2015—Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy mutation test for genotyping tumors of patients with advanced non-small cell lung cancer (NSCLC)
    Full story
  • Schizophrenia Genomics Study Looks for Somatic Mosaicism in Brain Cells

    May 20, 2015, 12:00 PM by Michael Croft
    Bio-IT World | The Lieber Institute for Brain Development (LIBD) announced a 5-year, $10.5 million grant from the National Institutes of Health (NIH) to support a first-of-its-kind multi-site, interdisciplinary project to research potentially non-inherited genetic causes of schizophrenia. By identifying the root biological origins now, more precise and effective therapies can be developed later.
    Full story
  • Celgene to Use Cypher Genomics’ Data Analytics in Drug Development

    May 20, 2015, 00:00 AM by Michael Croft
    Xconomy | Under a collaboration announced today, San Diego-based Cypher Genomics said it would use its biomarker discovery service to help New Jersey's Celgene identify key genetic variants among patients who respond well to specific drugs.
    Full story
  • Robert Gentleman on His Goals for Drug Discovery at 23andMe

    May 19, 2015, 11:00 AM by Michael Croft
    Bio-IT World | Robert Gentleman’s goal is to “bring bioinformatics and computational drug discovery to complement the really strong genetics” already at 23andMe. He spoke with Bio-IT World about open science at a for-profit venture, the challenges of drug discovery, and what’s left to find via SNP chips.
    Full story
  • Bluebird Regulators Map Out Approval Plan For Gene Therapy

    May 19, 2015, 00:00 AM by Michael Croft
    Xconomy | One of gene therapy's major unanswered questions is just what it'll take to convince U.S. regulators to approve one of these treatments.
    Full story